2019
Mavunda K, Jiang X , Ambrose C. The prevalence of diagnosed chronic lung disease in US infants by gestational age: Implications for RSV policy. Pediatric Academic Societies, Baltimore, MD, April 2019.
Publication: Abstracts and Presentations
Hooda N , Quinn E, DeAngelis C, Pasetka M, McFarlane T. 2019. Delayed CINV in FOLFOX chemotherapy: A retrospective chart review comparing two Ontario hospitals. Poster presented at the Canadian Association for Pharmacy in Oncology Annual Conference, Halifax, NS, April 2019.
Publication: Abstracts and Presentations
Babik I, Movva N , Cunha A, Lobo MA. 2019. Characterization of self-feeding and problem solving in children with arm movement impairments. Poster presented at the Society for Research in Child Development Biennial Conference, Baltimore, MD. March 2019.
Publication: Abstracts and Presentations
Mavunda K, Jiang X , Ambrose C. The prevalence of diagnosed chronic lung disease in US infants by gestational age: Implications for RSV policy. Celebration of Pediatric Pulmonology and Sleep, Orlando, FL, February 2019.
Publication: Abstracts and Presentations
Frankenfeld CL , Leslie TF, Menon N. Racial disparities in colorectal cancer time-to-treatment in relation to residential segregation of the diagnostic hospital. Poster presentation to American Public Health Association, 2019.
Publication: Abstracts and Presentations
2018
Garabrant DH, Pastula ST . 2018. A comparison of asbestos fiber potency and elongate mineral particle (EMP) potency for mesothelioma in humans. Toxicol Appl Pharmacol 361(15 Dec):127–136; doi: 10.1016/j.taap.2018.07.003 . PMID: 30077661.
View Abstract
Publication: Manuscripts
Frankenfeld CL . Residential segregation and health disparities. George Mason University Health Administration Policy/Center for Health Policy, Research, and Ethics Seminar, November 28, 2018.
Publication: Abstracts and Presentations
Fryzek JP, Bylsma LC , Nordyke RJ , Sorensen HT. Rare disease epidemiology: A Danish population-based program. Poster presented at National Organization for Rare Disorders’ Rare Disease and Orphan Products Breakthrough Summit, Washington, DC, October 2018.
Publication: Abstracts and Presentations
Jensen IS , Wu E, Sacks NC , Cyr PL , Chung KC. 2018. Budget impact analysis of using daunarubicin-cytarabine liposome in patients with newly diagnosed therapy-related AML or AML and myelodysplasia-related changes. Am Health Drug Benefits 11(7):380–386. PMID: 30647825 .
View Abstract
Publication: Manuscripts
Frankenfeld CL . Intersection of epidemiology and geography: Residential segregation and health disparities. George Mason University Geography and Geoinformation Science Colloquium, October 10, 2018.
A Division of